For the transition period from ___ to ___ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-34785 Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 1 ...

Financial Data and Key Metrics Changes - The company reported a net loss of $58.3 million for Q2 2020, compared to a net loss of $6.3 million in the same period last year, with over $48 million of this loss being non-cash due to revaluation of warrants and conversion options [27][30] - Cash and cash equivalents as of June 30, 2020, were $37.8 million, with total current assets at $39 million and total current liabilities at $19.6 million, resulting in positive working capital of $25.8 million, a significant improvement from a working capital deficiency of $12.3 million at the end of 2019 [30] Business Line Data and Key Metrics Changes - Traditional spa services remained closed during Q2 2020 due to government mandates, with no domestic spas anticipated to reopen in Q3 [8] - The new XpresCheck brand, providing COVID-19 screening and testing, has opened in two major international airports, JFK and Newark, with the capacity to test thousands of people weekly [10][19] Market Data and Key Metrics Changes - Airport traffic has been significantly impacted by COVID-19, with a noted increase in infections leading to reduced air travel and fewer passengers in terminals [8] - In 2019, 1.1 billion passengers passed through U.S. airports, indicating a substantial opportunity for testing services even with reduced travel [20] Company Strategy and Development Direction - The company aims to expand health and wellness services within airports, leveraging the XpresCheck concept to address the needs of airport workers and passengers [24] - Future plans include expanding testing to other communicable diseases and administering vaccinations, such as flu shots, at XpresCheck locations [25] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential for COVID-19 testing at major U.S. airports, likening its impact on health protocols to the changes in security protocols post-9/11 [19] - The company is actively lobbying for government financial assistance to support COVID-19 testing at airports, emphasizing the importance of returning to normalcy for the industry and economy [13] Other Important Information - The company has raised approximately $48 million in gross proceeds through equity offerings, which has strengthened its financial condition and provided flexibility for expansion [28][29] - The company is in discussions with several large hub U.S. airports to open new testing centers or convert existing XpresSpa locations to XpresCheck locations [22] Q&A Session Summary Question: Duration of JFK and Newark contracts - JFK has a longstanding relationship allowing for an amendment to the existing lease, while Newark has a one-year conditional use permit with potential for extension [33][34] Question: Delay in updates regarding Newark opening - The delay was due to administrative processes; the company has a policy of not making public statements until agreements are fully executed [34] Question: Cost comparison for repurposing existing spas vs. building new sites - Costs vary; modular kiosks may be less expensive due to prefabrication, while conversions involve more complexity [38][42] Question: Revenue model for testing sites - The company charges $75 for tests, with additional costs for lab work; insurance reimbursement can take time [46] Question: Opening sites to the public for testing - Initially focused on airport and airline employees to ensure system reliability before opening to the public [51] Question: Concerns about COVID screening developments in other regions - Management is not worried about obsolescence, as they can adapt to new technologies while prioritizing reliable testing methods [54] Question: Increase in testing due to quarantine regulations - There has been an increase in testing, but the quarantine rules do not allow for testing to reduce quarantine duration [57] Question: Plans to reopen traditional spas - Traditional spas will not reopen until there is sufficient airport traffic to support the business model [62] Question: Operating XpresCheck and XpresSpa simultaneously - The company can operate both services independently or concurrently at the same airport [66] Question: Current cash burn and future capital needs - Monthly operating costs are approximately $750,000, with sufficient cash reserves for several months; no immediate need to access shelf registration [70][71] Question: Deployment of rapid tests - The company is in discussions for rapid tests but has not finalized contracts; reliable quick tests are expected to increase patient interest [78][80]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number: 001-34785 XpresSpa Group, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 20-4988129 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number: 001-34785 XpresSpa Group, Inc. (Exact Name of Registrant as Specified in its Charter) (State or other jurisd ...

Financial Performance - XpresSpa generated $48.5 million in revenue for 2019, a decrease from $50.1 million in 2018, with approximately 82% of revenue from services[19] - Approximately 82% of XpresSpa's total revenue in both 2019 and 2018 was derived from services, primarily massage and nail care[19] - XpresSpa's stockholders' equity was in a deficit position as of December 31, 2019, raising compliance concerns with Nasdaq listing standards[45] - The company secured financing totaling approximately $9,440,000 in 2020 through cash advances, loans, and stock offerings to support operations during the COVID-19 crisis[30] Operational Impact of COVID-19 - Due to COVID-19, all global spa locations were temporarily closed starting March 24, 2020, significantly impacting cash flows and leading to a liquidity crisis[27] - The company temporarily closed all global locations on March 24, 2020, due to COVID-19, categorizing its services as "non-essential"[48] - XpresSpa temporarily closed all global spa locations on March 24, 2020, due to COVID-19, which has materially adversely impacted its operations and cash flows[27][29] - The company is exploring partnerships for COVID-19 testing in U.S. airports while awaiting the lifting of restrictions to resume normal operations[28][40] Location and Market Presence - The company operated 51 locations as of December 31, 2019, including 46 domestic and 5 international locations, providing about one million services and products annually[24] - XpresSpa operated 51 locations across 25 airports in three countries as of December 31, 2019, with a dominant market share in the U.S. and nearly three times the number of domestic locations as its closest competitor[24] - The largest domestic competitor operates only 15 locations, highlighting XpresSpa's significant market presence[34] Strategic Initiatives - Management plans to close nine underperforming spas, representing about 20% of the spa portfolio, to focus on profitable locations and expansion[32] - XpresSpa has strategic partnerships with Calm, Inc. and Persona™ to enhance product offerings in its locations[20][21] - The company has a flexible retail format, allowing it to adapt to various airport sizes and operate multiple stores within a single airport[38] - XpresSpa's business model allows for adaptation to space-constrained airports, enhancing its ability to secure new locations[38] Employee and Operational Plans - As of March 15, 2020, XpresSpa employed approximately 507 full-time and 221 part-time employees, with plans to reinstate furloughed employees once restrictions are lifted[47][48] - As of March 15, 2020, XpresSpa had approximately 507 full-time and 221 part-time employees, with many furloughed due to the pandemic[47][48] Company Background - The company rebranded from FORM Holdings Corp. to XpresSpa Group, Inc. on January 5, 2018, aligning its strategy with health and wellness services[49] - The company's common stock is traded under the symbol "XSPA" on the Nasdaq Capital Market since January 8, 2018[49] - The principal executive offices are located at 254 West 31 Street, 11 Floor, New York, New York 10001[49] - The company provides access to its filings with the SEC, including annual reports on Form 10-K and quarterly reports on Form 10-Q, available free of charge on its website[49] - The public can access SEC filings at the SEC's Public Reference Room and obtain information by calling the SEC[50]

XpresSpa Group | --- | --- | --- | --- | --- | --- | |--------------|---------------------------|------------|-------|-------|-------| | | | | | | | | a preeminent | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | pure-play | health and | | | | | | | | | | | | | wellness services company | | | | | | | | | | | | INVESTOR PRESENTATION 2020 | JANUARY ICR CONFERENCE NASDAQ: XSPA Disclaimers Safe Harbor Statement This presentation includes forward-looking statements, which may be identified ...

Start Time: 17:00 January 1, 0000 5:30 PM ET XpresSpa Group, Inc. (XSPA) Q3 2019 Earnings Conference Call November 14, 2019, 17:00 PM ET Company Participants Doug Satzman - CEO Conference Call Participants Operator Greetings, and welcome to the XpresSpa Group, Inc.'s Third Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode, and a question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recor ...

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number: 001-34785 XpresSpa Group, Inc. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of inco ...

XpresSpa Group, Inc. (XSPA) Q2 2019 Results Earnings Conference Call August 14, 2019 4:30 PM ET Company Participants Doug Satzman - Chief Executive Officer Conference Call Participants Operator Greetings and welcome to XpresSpa Group, Inc.'s second quarter 2019 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. Today's conference call ...

Revenue Performance - XpresSpa generated $25,138 in revenue for the six-month period ended June 30, 2019, compared to $25,638 for the same period in 2018, representing a decrease of approximately 2%[160]. - Total revenues for the six months ended June 30, 2019, were $25,138, a decrease from $25,638 in the same period of 2018[196]. - Revenue for the three-month period ended June 30, 2019, decreased by $130 or 1% to $12,908 compared to $13,038 in 2018, primarily due to a reduction in the number of spas open from 57 to 54[204]. - Approximately 81% of XpresSpa's total revenue for the six-month period ended June 30, 2019, was generated by services, primarily massage and nail care[160]. Financial Position - As of June 30, 2019, total current liabilities were $8,451, resulting in a working capital deficiency of $4,632[175]. - The working capital deficiency was reduced from $10,899 as of December 31, 2018, to $4,632 as of June 30, 2019, due to refinancing transactions[230]. - Cash and cash equivalents as of June 30, 2019, were $2,259, a decrease of $1,144 from $3,403 as of December 31, 2018, primarily due to capital expenditures and debt service payments[229]. Operating Performance - Positive cash flows from continuing operations were $244 for the six months ended June 30, 2019, compared to a cash loss of $5,061 for the same period in 2018[176]. - The Company experienced a loss from continuing operations of $3,967 for the six months ended June 30, 2019, compared to a loss of $26,124 in the same period of 2018[196]. - The Company reported a net loss attributable to common shareholders of $9,311 for the six months ended June 30, 2019, compared to a net loss of $27,456 in the same period of 2018[196]. - Adjusted EBITDA for the three months ended June 30, 2019, was a loss of $441, an improvement from a loss of $538 in the same period of 2018[196]. Cost Management - Total cost of sales for the six-month period decreased by $1,185 or 5.9% to $18,951, reflecting both reduced revenue and management's cost-reduction initiatives[217]. - Cost of sales for the same period decreased by $506 or 4.9% to $9,853, attributed to management initiatives aimed at streamlining processes and reducing store-level costs[205]. - General and administrative expenses decreased by $1,408 or 36.1% to $2,496, mainly due to reduced salaries and benefits for executive management personnel[211]. - Depreciation and amortization expenses for the six-month period decreased by $268 or 7.7% to $3,228, primarily due to fewer locations open[219]. Debt and Financing - The company received $2,500 in gross proceeds from the Calm Private Placement, which increased its cash balance and reduced working capital deficiency by the same amount[162][175]. - The Calm Notes, which are unsecured convertible notes, will mature on May 31, 2022, and bear interest at a rate of 5% per annum[163]. - The B3D Notes, which are senior secured obligations, will mature on May 31, 2021, and bear interest at a rate of 9% per annum[168]. - The Company reduced the conversion price of Convertible Notes from $12.40 to $2.48 per share, resulting in a debt conversion expense of $1,547 recorded in "Other non-operating income (expense), net" for the quarter ended June 30, 2019[177]. Strategic Initiatives - The company has aggressively reduced operating and overhead expenses while focusing on overall profitability despite expecting net losses in the foreseeable future[176]. - The Company plans to grow by focusing on spa-level productivity and leveraging retail partnerships to increase units per transaction[191]. - The Company entered into an Amended and Restated Product Sale and Marketing Agreement with Calm, effective July 8, 2019, to enhance product sales in its stores[187]. Market and Risk Factors - The company continues to experience operating losses and may need to secure additional sources of funds if liquidity is not generated[236]. - There have been no material changes to the company's critical accounting policies, which involve subjective and complex judgments[237]. - The company is classified as a smaller reporting company, thus not required to disclose quantitative and qualitative disclosures about market risk[239].